Medical Heparin - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for Medical Heparin should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Medical Heparin market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Medical Heparin market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Treatment of Thrombotic Diseases grew percent to account for percent of the total market sales, and Postoperative Rehabilitation grew percent.
Heparin is an anticoagulant drug commonly used to prevent and treat thrombotic diseases. It is a natural polysaccharide substance secreted by liver cells and lung cells, which has the effect of inhibiting thrombin and preventing blood from clotting in blood vessels.
Heparin is usually administered by intravenous or subcutaneous injection. It is widely used in cardiac surgery, hemodialysis, treatment of thrombotic diseases, and other situations that require anticoagulation. Unlike other anticoagulants, the effect of heparin is reversible, which makes it very useful in situations where anticoagulation needs to be quickly stopped, such as during surgery.
However, the use of heparin also carries some risks, such as bleeding and other side effects. Therefore, before using heparin, doctors will assess the risks and benefits based on the patient's specific condition and develop a personalized treatment plan.
This report studies and analyses global Medical Heparin status and future trends, helps the client to determine the Medical Heparin market size of the total market opportunity by Molecular Weight, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Medical Heparin, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Medical Heparin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Medical Heparin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Medical Heparin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Medical Heparin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Medical Heparin key producing regions, capacity, production, and year over year growth
(6) Medical Heparin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Hepalink
Changshan Pharm
Pfizer
Bioberica
Criticine Care
SmithField BioScience
Sanofi
Fresenius Kabi
Aspen Pharmacare
LEO Pharma
Baxter Healthcare
Cardinal Health
SwissPAR
Fierce Pharma
Market segment by Molecular Weight, covers
High Molecular Weight Heparin (HMWH)
Low Molecular Weight Heparin (LMWH)
Market segment by Application, can be divided into
Treatment of Thrombotic Diseases
Postoperative Rehabilitation
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Medical Heparin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Medical Heparin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Medical Heparin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Medical Heparin, percent & CAGR, 2018-2029
Chapter 5: Medical Heparin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Medical Heparin Definition
1.2 Global Medical Heparin Market Size and Forecast
1.2.1 By Consumption Value, Global Medical Heparin Market Size，2019-2030
1.2.2 By Sales Quantity, Global Medical Heparin Market Size，2019-2030
1.2.3 Global Medical Heparin Average Selling Price (ASP)，2019-2030
1.3 China Medical Heparin Market Size and Forecast
1.3.1 By Consumption Value, China Medical Heparin Market Size，2019-2030
1.3.2 By Sales Quantity, China Medical Heparin Market Size，2019-2030
1.3.3 China Medical Heparin Average Selling Price (ASP)， 2019-2030
1.4 Share of China Medical Heparin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Medical Heparin Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Medical Heparin Market Share in Global, 2019-2030
1.4.3 Medical Heparin Market Size: China VS Global, 2019-2030
1.5 Medical Heparin Market Dynamics
1.5.1 Medical Heparin Market Drivers
1.5.2 Medical Heparin Market Restraints
1.5.3 Medical Heparin Industry Trends
1.5.4 Medical Heparin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Medical Heparin, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Medical Heparin, Global Market Share by Company, 2019-2024
2.3 Medical Heparin Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Medical Heparin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Medical Heparin Concentration Ratio
2.6 Global Medical Heparin Mergers & Acquisitions, Expansion Plans
2.7 Global Medical Heparin Manufacturers Product Type
2.8 Head Office and Medical Heparin Production Site of Key Manufacturer
2.9 Medical Heparin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Medical Heparin, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Medical Heparin, China Market Share by Company, 2019-2024
3.3 China Medical Heparin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Medical Heparin Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Medical Heparin Capacity by Region
4.3 Global Medical Heparin Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Medical Heparin Production by Region, 2019-2030
4.5 Global Medical Heparin Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Medical Heparin Industry Chain
5.2 Medical Heparin Upstream Analysis
5.2.1 Medical Heparin Core Raw Materials
5.2.2 Main Manufacturers of Medical Heparin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medical Heparin Production Mode
5.6 Medical Heparin Procurement Model
5.7 Medical Heparin Industry Sales Model and Sales Channels
5.7.1 Medical Heparin Sales Model
5.7.2 Medical Heparin Typical Distributors
6 Sights by Molecular Weight
6.1 Medical Heparin Classification
6.1.1 High Molecular Weight Heparin (HMWH)
6.1.2 Low Molecular Weight Heparin (LMWH)
6.2 By Molecular Weight, Global Medical Heparin Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Molecular Weight, Global Medical Heparin Consumption Value, 2019-2030
6.4 By Molecular Weight, Global Medical Heparin Sales Quantity, 2019-2030
6.5 By Molecular Weight, Global Medical Heparin Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Medical Heparin Segment by Application
7.1.1 Treatment of Thrombotic Diseases
7.1.2 Postoperative Rehabilitation
7.1.3 Others
7.2 By Application, Global Medical Heparin Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Medical Heparin Consumption Value, 2019-2030
7.4 By Application, Global Medical Heparin Sales Quantity, 2019-2030
7.5 By Application, Global Medical Heparin Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Medical Heparin Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Medical Heparin Consumption Value, 2019-2030
8.3 By Region, Global Medical Heparin Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Medical Heparin & Forecasts, 2019-2030
8.4.2 By Country, North America Medical Heparin Market Size Market Share
8.5 Europe
8.5.1 Europe Medical Heparin Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Medical Heparin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Medical Heparin Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Medical Heparin Market Size Market Share
8.7 South America
8.7.1 South America Medical Heparin Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Medical Heparin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Medical Heparin Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Medical Heparin Consumption Value, 2019-2030
9.3 By Country, Global Medical Heparin Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Medical Heparin Market Size, 2019-2030
9.4.2 By Molecular Weight, U.S. Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Medical Heparin Market Size, 2019-2030
9.5.2 By Molecular Weight, Europe Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Medical Heparin Market Size, 2019-2030
9.6.2 By Molecular Weight, China Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Medical Heparin Market Size, 2019-2030
9.7.2 By Molecular Weight, Japan Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Medical Heparin Market Size, 2019-2030
9.8.2 By Molecular Weight, South Korea Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Medical Heparin Market Size, 2019-2030
9.9.2 By Molecular Weight, Southeast Asia Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Medical Heparin Market Size, 2019-2030
9.10.2 By Molecular Weight, India Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Medical Heparin Market Size, 2019-2030
9.11.2 By Molecular Weight, Middle East & Africa Medical Heparin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Medical Heparin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Hepalink
10.1.1 Hepalink Company Information, Head Office, Market Area, and Industry Position
10.1.2 Hepalink Medical Heparin Models, Specifications, and Application
10.1.3 Hepalink Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Hepalink Company Profile and Main Business
10.1.5 Hepalink Recent Developments
10.2 Changshan Pharm
10.2.1 Changshan Pharm Company Information, Head Office, Market Area, and Industry Position
10.2.2 Changshan Pharm Medical Heparin Models, Specifications, and Application
10.2.3 Changshan Pharm Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Changshan Pharm Company Profile and Main Business
10.2.5 Changshan Pharm Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.3.2 Pfizer Medical Heparin Models, Specifications, and Application
10.3.3 Pfizer Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Bioberica
10.4.1 Bioberica Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bioberica Medical Heparin Models, Specifications, and Application
10.4.3 Bioberica Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Bioberica Company Profile and Main Business
10.4.5 Bioberica Recent Developments
10.5 Criticine Care
10.5.1 Criticine Care Company Information, Head Office, Market Area, and Industry Position
10.5.2 Criticine Care Medical Heparin Models, Specifications, and Application
10.5.3 Criticine Care Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Criticine Care Company Profile and Main Business
10.5.5 Criticine Care Recent Developments
10.6 SmithField BioScience
10.6.1 SmithField BioScience Company Information, Head Office, Market Area, and Industry Position
10.6.2 SmithField BioScience Medical Heparin Models, Specifications, and Application
10.6.3 SmithField BioScience Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 SmithField BioScience Company Profile and Main Business
10.6.5 SmithField BioScience Recent Developments
10.7 Sanofi
10.7.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.7.2 Sanofi Medical Heparin Models, Specifications, and Application
10.7.3 Sanofi Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Sanofi Company Profile and Main Business
10.7.5 Sanofi Recent Developments
10.8 Fresenius Kabi
10.8.1 Fresenius Kabi Company Information, Head Office, Market Area, and Industry Position
10.8.2 Fresenius Kabi Medical Heparin Models, Specifications, and Application
10.8.3 Fresenius Kabi Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Fresenius Kabi Company Profile and Main Business
10.8.5 Fresenius Kabi Recent Developments
10.9 Aspen Pharmacare
10.9.1 Aspen Pharmacare Company Information, Head Office, Market Area, and Industry Position
10.9.2 Aspen Pharmacare Medical Heparin Models, Specifications, and Application
10.9.3 Aspen Pharmacare Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Aspen Pharmacare Company Profile and Main Business
10.9.5 Aspen Pharmacare Recent Developments
10.10 LEO Pharma
10.10.1 LEO Pharma Company Information, Head Office, Market Area, and Industry Position
10.10.2 LEO Pharma Medical Heparin Models, Specifications, and Application
10.10.3 LEO Pharma Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 LEO Pharma Company Profile and Main Business
10.10.5 LEO Pharma Recent Developments
10.11 Baxter Healthcare
10.11.1 Baxter Healthcare Company Information, Head Office, Market Area, and Industry Position
10.11.2 Baxter Healthcare Medical Heparin Models, Specifications, and Application
10.11.3 Baxter Healthcare Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Baxter Healthcare Company Profile and Main Business
10.11.5 Baxter Healthcare Recent Developments
10.12 Cardinal Health
10.12.1 Cardinal Health Company Information, Head Office, Market Area, and Industry Position
10.12.2 Cardinal Health Medical Heparin Models, Specifications, and Application
10.12.3 Cardinal Health Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Cardinal Health Company Profile and Main Business
10.12.5 Cardinal Health Recent Developments
10.13 SwissPAR
10.13.1 SwissPAR Company Information, Head Office, Market Area, and Industry Position
10.13.2 SwissPAR Medical Heparin Models, Specifications, and Application
10.13.3 SwissPAR Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 SwissPAR Company Profile and Main Business
10.13.5 SwissPAR Recent Developments
10.14 Fierce Pharma
10.14.1 Fierce Pharma Company Information, Head Office, Market Area, and Industry Position
10.14.2 Fierce Pharma Medical Heparin Models, Specifications, and Application
10.14.3 Fierce Pharma Medical Heparin Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Fierce Pharma Company Profile and Main Business
10.14.5 Fierce Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Medical Heparin Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Medical Heparin Market Restraints
Table 3. Medical Heparin Market Trends
Table 4. Medical Heparin Industry Policy
Table 5. Global Medical Heparin Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Medical Heparin Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Medical Heparin Sales Quantity by Company, (2019-2024) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Medical Heparin Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Medical Heparin Average Selling Price (ASP) by Company, (2019-2024) & (US$/Ton)
Table 10. Global Medical Heparin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Medical Heparin Mergers & Acquisitions, Expansion Plans
Table 12. Global Medical Heparin Manufacturers Product Type
Table 13. Head Office and Medical Heparin Production Site of Key Manufacturer
Table 14. Medical Heparin Capacity of Major Manufacturers and Future Plan
Table 15. China Medical Heparin Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Medical Heparin Sales Quantity by Company, (2019-2024) & (Tons), Ranked Based on Sales in 2022
Table 17. China Medical Heparin Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Medical Heparin Production & Forecast by Region, 2019 VS 2024 VS 2030, (Tons)
Table 19. Global Medical Heparin Production by Region, 2019-2024, (Tons)
Table 20. Global Medical Heparin Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Medical Heparin Upstream (Raw Materials)
Table 22. Global Medical Heparin Typical Customers
Table 23. Medical Heparin Typical Distributors
Table 24. By Molecular Weight, Global Medical Heparin Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Medical Heparin Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Medical Heparin Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Medical Heparin Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Medical Heparin Sales Quantity, 2019-2030, (Tons)
Table 29. By Country, Global Medical Heparin Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Medical Heparin Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Medical Heparin Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Medical Heparin Sales Quantity, 2019-2030, (Tons)
Table 33. By Country, Global Medical Heparin Sales Quantity Market Share, 2019-2030
Table 34. Hepalink Company Information, Head Office, Market Area, and Industry Position
Table 35. Hepalink Medical Heparin Models, Specifications, and Application
Table 36. Hepalink Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 37. Hepalink Company Profile and Main Business
Table 38. Hepalink Recent Developments
Table 39. Changshan Pharm Company Information, Head Office, Market Area, and Industry Position
Table 40. Changshan Pharm Medical Heparin Models, Specifications, and Application
Table 41. Changshan Pharm Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 42. Changshan Pharm Company Profile and Main Business
Table 43. Changshan Pharm Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 45. Pfizer Medical Heparin Models, Specifications, and Application
Table 46. Pfizer Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. Bioberica Company Information, Head Office, Market Area, and Industry Position
Table 50. Bioberica Medical Heparin Models, Specifications, and Application
Table 51. Bioberica Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 52. Bioberica Company Profile and Main Business
Table 53. Bioberica Recent Developments
Table 54. Criticine Care Company Information, Head Office, Market Area, and Industry Position
Table 55. Criticine Care Medical Heparin Models, Specifications, and Application
Table 56. Criticine Care Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 57. Criticine Care Company Profile and Main Business
Table 58. Criticine Care Recent Developments
Table 59. SmithField BioScience Company Information, Head Office, Market Area, and Industry Position
Table 60. SmithField BioScience Medical Heparin Models, Specifications, and Application
Table 61. SmithField BioScience Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 62. SmithField BioScience Company Profile and Main Business
Table 63. SmithField BioScience Recent Developments
Table 64. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 65. Sanofi Medical Heparin Models, Specifications, and Application
Table 66. Sanofi Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 67. Sanofi Company Profile and Main Business
Table 68. Sanofi Recent Developments
Table 69. Fresenius Kabi Company Information, Head Office, Market Area, and Industry Position
Table 70. Fresenius Kabi Medical Heparin Models, Specifications, and Application
Table 71. Fresenius Kabi Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 72. Fresenius Kabi Company Profile and Main Business
Table 73. Fresenius Kabi Recent Developments
Table 74. Aspen Pharmacare Company Information, Head Office, Market Area, and Industry Position
Table 75. Aspen Pharmacare Medical Heparin Models, Specifications, and Application
Table 76. Aspen Pharmacare Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 77. Aspen Pharmacare Company Profile and Main Business
Table 78. Aspen Pharmacare Recent Developments
Table 79. LEO Pharma Company Information, Head Office, Market Area, and Industry Position
Table 80. LEO Pharma Medical Heparin Models, Specifications, and Application
Table 81. LEO Pharma Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 82. LEO Pharma Company Profile and Main Business
Table 83. LEO Pharma Recent Developments
Table 84. Baxter Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 85. Baxter Healthcare Medical Heparin Models, Specifications, and Application
Table 86. Baxter Healthcare Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 87. Baxter Healthcare Company Profile and Main Business
Table 88. Baxter Healthcare Recent Developments
Table 89. Cardinal Health Company Information, Head Office, Market Area, and Industry Position
Table 90. Cardinal Health Medical Heparin Models, Specifications, and Application
Table 91. Cardinal Health Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 92. Cardinal Health Company Profile and Main Business
Table 93. Cardinal Health Recent Developments
Table 94. SwissPAR Company Information, Head Office, Market Area, and Industry Position
Table 95. SwissPAR Medical Heparin Models, Specifications, and Application
Table 96. SwissPAR Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 97. SwissPAR Company Profile and Main Business
Table 98. SwissPAR Recent Developments
Table 99. Fierce Pharma Company Information, Head Office, Market Area, and Industry Position
Table 100. Fierce Pharma Medical Heparin Models, Specifications, and Application
Table 101. Fierce Pharma Medical Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2019-2024
Table 102. Fierce Pharma Company Profile and Main Business
Table 103. Fierce Pharma Recent Developments
List of Figures
Figure 1. Medical Heparin Picture
Figure 2. Global Medical Heparin Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Medical Heparin Sales Quantity, (Tons) & (2019-2030)
Figure 4. Global Medical Heparin Average Selling Price (ASP), (2019-2030) & (US$/Ton)
Figure 5. China Medical Heparin Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Medical Heparin Sales Quantity (Tons) & (2019-2030)
Figure 7. China Medical Heparin Average Selling Price (ASP), (US$/Ton) & (2019-2030)
Figure 8. By Consumption Value, China Medical Heparin Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Medical Heparin Market Share of Global, 2019-2030
Figure 10. Global Medical Heparin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Medical Heparin Key Participants, Market Share, 2022
Figure 12. Global Medical Heparin Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Medical Heparin Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Medical Heparin Production Market Share & Forecast by Region, 2019-2030
Figure 15. Medical Heparin Industry Chain
Figure 16. Medical Heparin Procurement Model
Figure 17. Medical Heparin Sales Model
Figure 18. Medical Heparin Sales Channels, Direct Sales, and Distribution
Figure 19. High Molecular Weight Heparin (HMWH)
Figure 20. Low Molecular Weight Heparin (LMWH)
Figure 21. By Molecular Weight, Global Medical Heparin Consumption Value, 2019-2030, US$ Million
Figure 22. By Molecular Weight, Global Medical Heparin Consumption Value Market Share, 2019-2030
Figure 23. By Molecular Weight, Global Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 24. By Molecular Weight, Global Medical Heparin Sales Quantity Market Share, 2019-2030
Figure 25. By Molecular Weight, Global Medical Heparin Average Selling Price (ASP), 2019-2030, (US$/Ton)
Figure 26. Treatment of Thrombotic Diseases
Figure 27. Postoperative Rehabilitation
Figure 28. Others
Figure 29. By Application, Global Medical Heparin Consumption Value, 2019-2030, US$ Million
Figure 30. By Application, Global Medical Heparin Consumption Value Market Share, 2019-2030
Figure 31. By Application, Global Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 32. By Application, Global Medical Heparin Sales Quantity Market Share, 2019-2030
Figure 33. By Application, Global Medical Heparin Average Selling Price (ASP), 2019-2030, (US$/Ton)
Figure 34. By Region, Global Medical Heparin Consumption Value Market Share, 2019-2030
Figure 35. By Region, Global Medical Heparin Sales Quantity Market Share, 2019-2030
Figure 36. North America Medical Heparin Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 37. By Country, North America Medical Heparin Consumption Value Market Share, 2022
Figure 38. Europe Medical Heparin Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 39. By Country, Europe Medical Heparin Consumption Value Market Share, 2022
Figure 40. Asia Pacific Medical Heparin Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 41. By Country/Region, Asia Pacific Medical Heparin Consumption Value Market Share, 2022
Figure 42. South America Medical Heparin Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, South America Medical Heparin Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Medical Heparin Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 45. U.S. Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 46. By Molecular Weight, U.S. Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 49. By Molecular Weight, Europe Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 52. By Molecular Weight, China Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 55. By Molecular Weight, Japan Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 58. By Molecular Weight, South Korea Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 61. By Molecular Weight, Southeast Asia Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 64. By Molecular Weight, India Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Medical Heparin Sales Quantity, 2019-2030, (Tons)
Figure 67. By Molecular Weight, Middle East & Africa Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Medical Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|